Journals / Tıp Araştırmaları Dergisi / 2013 / Cilt: 11 - Sayı: 2

Retinal Nerve Fiber Layer and Diabetes

Retina Sinir Lifi Tabakası ve Diyabet

Pages
87–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article aims to review the retinal nerve fiber layer (RNFL) and retinal nerve fiber analysis techniques and to evaluate the effect of diabet and metabolic control on RNFL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetic retinopathy (DR) is the most commonly seen complication of Diabetes mellitus (DM) and the most significant cause of blindness between the ages of 20 and 65.
📊
Key Findings & Data:It was clinically demonsrated that hyperglicemia may lead to functional changes prior to the development of retinopathy.
💡
Conclusion & Impact:This article aims to review the retinal nerve fiber layer (RNFL) and retinal nerve fiber analysis techniques and to evaluate the effect of diabet and metabolic control on RNFL.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diabetic retinopathy (DR) is the most commonly seen complication of Diabetes mellitus (DM) and the most significant cause of blindness between the ages of 20 and 65. It was clinically demonsrated that hyperglicemia may lead to functional changes prior to the development of retinopathy. The most significant in the course of DM is that the functional deficits should be determined before ophtalmological changes occur, and the development of the disease should be prevented. It is a well-known fact that metabolic control plays a key role in the prevention of DR in patients with DM. This article aims to review the retinal nerve fiber layer (RNFL) and retinal nerve fiber analysis techniques and to evaluate the effect of diabet and metabolic control on RNFL.

Özet

Diyabetik retinopati (DR) diyabetes mellitusun en sık görülen komplikasyonudur ve 20-65 ya arası körlü ün en önemli nedenidir. Klinik olarak retinopati geli meden önce hipergliseminin fonksiyonel de i ikliklere neden oldu u gösterilmi tir. Diyabetin seyrinde önemli olan oftalmoskopik de i iklikler olu madan bu erken fonksiyonel kayıpların tespiti ve hastalı ın ilerlemesinin önlenmesidir. Diyabetes mellitus (DM)'li hastalarda, diyabetik retinopatinin önlenmesinde metabolik kontrolün önemi bilinmektedir. Bu yazı retina sinir lifi tabakası (RSLT) ve retina sinir lifi analiz tekniklerini incelemek, diyabetes mellitus ve metabolik kontrolün RSLT'ye etkisini de erlendirmek amacını taşımaktadır.

🔖

Cite This Article

GÖNÜL, Ş., KADIOĞLU, E. (2013). Retinal Nerve Fiber Layer and Diabetes. Tıp Araştırmaları Dergisi, Cilt: 11 - Sayı: 2, 87–93. https://ajindex.com/articles/361845

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Schubert HD. Structure and fonction of the neural retina. In: Yanoff M, Duker JS, ed. Ophthalmology 1999 ch 8-1, p. l-2. Kanski JJ. The Glaucomas. In: Clinical Ophthalmology. Butternworth Heinemann. Internationale Edition. Oxford 1994, p. 233-284.
  2. Weinreb RN, Shakiba S, Zangwill L. Scanning laser polarimetry to measure the nerve fiber layer of normal and glaucomatous eyes. Am Ophthalmol 1995; 119: 627-636.
  3. Quigley HA, Reacher M, Katz J, Strahlman E, Gilbert D, Scott R. Quantitative grading of nerve fiber layer photographs. Ophthalmology 1993; 100:1800-1807.
  4. Sommer A, Quigley HA, Robin AL, Miller NR, Katz J, Arkell S. Evaluation of nevre fiber layer assessment. Arch Ophthalmol 1984; 102: 1766- 1771. Caprioli J. The contour of the juxtapapillary nerve fiber layer in glaucoma. Ophthalmol 1990; 97: 358-366.
  5. Bozkurt B, İrkeç M, Akar Y, Oran M. Glokomda retina sinir lifi tabakas1 görüntüleme yöntemleri. Türk Oftalmoloji Dergisi 2003; 33: 543-553.
  6. Kruse FE, Burk ROW, Volcker HE, Zinser G, Harbarth U. Reproducibility of topografic measurements of the optic nerve head with laser tomographic scanning. Ophthalmology 1989; 96: 1320-1324.
  7. Weinreb RN, Dreher AW, Coleman A, Quigley H, Shaw B, Reiter K. Histopathologic validation of Fourier-ellipsometry measurements of retinal nerve fiber layer thickness. Arch Ophthalmol 1990; 108: 557-560.
  8. Dreher AW, Reiter K, Weinreb RN. Spatially resolved birefringence of the retinal nerve fiber layer assessed with retinal ellipsometer. Appl Optics 1992; 31: 3730-3735.
  9. Zangwill L, Berry CA, Garden VS, Weinreb RN. Reproducibility of retardation measurements with the nerve fiber layer analyser II. Glaucoma 1997; 6: 384-389.
  10. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991; 254: 1178- 1181. Puliafito CA, Hee MR, Schuman JS, Fujimoto JG. Optical Coherence Tomography of Ocular Diseases. Boston, Slack 1996; 36: 289-356. Optical Coherence Tomography Scanner Owner's Manual. REV. B: Humphrey Systems. Division of Carl Zeiss, Inc. 1998. American Academy of Ophthalmology. Optic nerve head and retinal nerve fiber layer analysis. Ophthalmology. 1999; 106: 1414-1424.
  11. Swanson EA, Izatt FA, Hee MR, et al. In vivo retinal imaging by optical coherence tomography. Optics Letters. 1993; 18: 1864-1866.
  12. Porta M, Bandello F. Diabetic Diabetologia 2002; 45: 1617-1634.
  13. Oshitari T, Mitamura Y. Optical coherence tomography for complete management of patients with diabetic retinopathy. Curr Diabetes Rev. 2010;6:207-214.
  14. Sokol S, Mosko